Hocaoğlu Aksay, N. Et Al. 2012. Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects?. Cardiovascular toxicology , vol.12, no.2 , 115-22.

Hocaoğlu Aksay, N., Kalkan, Ş., Büyükdeligöz, M., Oransay, K., & Tunçok, Y., (2012). Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects?. Cardiovascular toxicology , vol.12, no.2, 115-22.

Hocaoğlu Aksay, NİL Et Al. "Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects?," Cardiovascular toxicology , vol.12, no.2, 115-22, 2012

Hocaoğlu Aksay, NİL H. Et Al. "Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects?." Cardiovascular toxicology , vol.12, no.2, pp.115-22, 2012

Hocaoğlu Aksay, N. Et Al. (2012) . "Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects?." Cardiovascular toxicology , vol.12, no.2, pp.115-22.

@article{article, author={NİL HOCAOĞLU AKSAY Et Al. }, title={Is serum S100B protein a biomarker for amitriptyline-induced cardiovascular toxic effects?}, journal={Cardiovascular toxicology}, year=2012, pages={115-22} }